enVVeno Medical Corporation — Income Charts
6 years of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-13.7% -$26K
$161K
Cost of Revenue
$420K
Gross Profit
$187K
R&D↑+700.3% +$9M
$10M
SG&A↑+131.7% +$9M
$15M
D&A↑+58.9% +$79K
$212K
Operating Income↓-217.4% -$17M
$-25M
EBITDA↓-220.2% -$17M
$-25M
Interest Expense
$305K
Other Income/Expense
—
Pretax Income
—
Net Income↓-89.1% -$12M
$-25M
Gross Margin
100.0%
Operating Margin↓-11275.2pts
-15485.7%
Net Margin↓-8330.9pts
-15322.4%
Deferred Tax Assets↑+205.2% +$13M
$19M
Deferred Tax Liabilities
$71K
DTA Valuation Allowance↑+252.8% +$10M
$14M
Tax Credit Carryforwards↑+0.2% +$320
$186K
NOL Carryforwards↓-15.2% -$3M
$15M
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+1.9pts
-5.1%
ETR Foreign Differential (pp)
2.0%
Operating Lease Cost↑+11.7% +$41K
$389K
Revenue YoY Variation↑+803.2pts
747.4%
Income YoY Variation↓-18.9pts
-47.6%